Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ironwood Pharmaceuticals

0.6870
-0.0511-6.92%
Volume:1.76M
Turnover:1.24M
Market Cap:111.17M
PE:-3.40
High:0.7422
Open:0.7370
Low:0.6701
Close:0.7381
Loading ...
May 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Dec 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2023

Correspondence

Form CORRESP - Correspondence
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 11, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 11, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities